Specialists for Giant cell glioblastoma

56 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Mark G Malkin, MD, MD, FRCPC, FAAN
Rare Disease / Clinical Research
Massey Cancer Center
RICHMOND, VA
QC-verified PI×1
Alan K Meeker
Rare Disease / Clinical Research
Johns Hopkins University School of Medicine
QC-verified 1
Liliana Mocanu
Rare Disease / Clinical Research
Clinical Service of Pathology
QC-verified 1
Mariana Deacu
Rare Disease / Clinical Research
Clinical Service of Pathology
QC-verified 1
Mariana Aschie
Rare Disease / Clinical Research
Clinical Service of Pathology
QC-verified 1
Cristian Ionut Orasanu
Rare Disease / Clinical Research
Clinical Service of Pathology
QC-verified 1
Salem Al-Dwairy
Rare Disease / Clinical Research
The Hashemite University
QC-verified 1
Alaa Al-Mousa
Rare Disease / Clinical Research
The Hashemite University
QC-verified 1
Christopher M Heaphy
Rare Disease / Clinical Research
Johns Hopkins University School of Medicine
QC-verified 1
Fausto J Rodriguez
Rare Disease / Clinical Research
Johns Hopkins University School of Medicine
QC-verified 1
Bill H Diplas, MD, PhD
Rare Disease / Clinical Research
Duke University Medical Center
NEW YORK, NY
QC-verified 1
Christine M Davis
Rare Disease / Clinical Research
Johns Hopkins University School of Medicine
QC-verified 1
Jacqueline A Brosnan-Cashman
Rare Disease / Clinical Research
Johns Hopkins University School of Medicine
QC-verified 1
Georgeta Camelia Cozaru
Rare Disease / Clinical Research
Clinical Service of Pathology
QC-verified 1
Theodor Sebastian Topliceanu
Rare Disease / Clinical Research
"Ovidius" University of Constanta
QC-verified 1
Raluca Ioana Voda
Rare Disease / Clinical Research
Clinical Service of Pathology
QC-verified 1
David Peereboom, MD, M.D
Rare Disease / Clinical Research
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
CLEVELAND, OH
PI×10
Phioanh Nghiemphu, MD
Rare Disease / Clinical Research
University of California at Los Angeles (UCLA )
LOS ANGELES, CA
PI×2
Patrick Y Wen, MD
Rare Disease / Clinical Research
National Cancer Institute (NCI)
BOSTON, MA
PI×1 12
Jana Portnow, MD
Rare Disease / Clinical Research
City of Hope Medical Center
DUARTE, CA
PI×4
Ernest C. Borden, MD
Rare Disease / Clinical Research
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
PI×5
Patrick Wen, MD, MD
Rare Disease / Clinical Research
National Cancer Institute (NCI)
BOSTON, MA
PI×6
John Grecula, MD
Rare Disease / Clinical Research
Ohio State University
COLUMBUS, OH
PI×1
Timothy F. Cloughesy, MD, MD
Rare Disease / Clinical Research
Jonsson Comprehensive Cancer Center
LOS ANGELES, CA
PI×4
Jana Portnow, MD, MD
Rare Disease / Clinical Research
City of Hope Comprehensive Cancer Center
DUARTE, CA
PI×3
Charles Nock, MD, M.D
Rare Disease / Clinical Research
National Cancer Institute (NCI)
CLEVELAND, OH
PI×1
Manmeet Ahluwalia, MD
Rare Disease / Clinical Research
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
MIAMI, FL
PI×1
Eudocia Q Lee, MD
Rare Disease / Clinical Research
NRG Oncology
BOSTON, MA
PI×2 238
Wenyin Shi, MD, PhD, MD, PHD
Rare Disease / Clinical Research
Thomas Jefferson University
PHILADELPHIA, PA
PI×5
Sebastien Hotte
Rare Disease / Clinical Research
University Health Network-Princess Margaret Hospital
PI×1
Lauren Abrey, MD, MD
Rare Disease / Clinical Research
National Cancer Institute (NCI)
NEW YORK, NY
PI×1 1
Antonio Omuro, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
STANFORD, CA
PI×1
Behnam Badie, MD
Rare Disease / Clinical Research
City of Hope Medical Center
ARCADIA, CA
PI×3 1
Boehringer Ingelheim
Rare Disease Specialist
The Institute for Liver Health II DBA Arizona Clinical Trials
Peoria, Arizona
PI×157
Sarah J. Nelson, PhD
Rare Disease / Clinical Research
University of California, San Francisco
PI×1
Tom Mikkelsen, M.D
New Approaches to Brain Tumor Therapy Consortium
DETROIT, MI
QC-verified PI×1
Eric C Burton
National Cancer Institute (NCI)
QC-verified PI×1
Sarah F Katta, D.O
Rare Disease / Clinical Research
ORLANDO, FL
PI×1
Frederic Di Fiore
Centre Henri Becquerel
QC-verified PI×1
Frank A. Giordano
Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Germany
QC-verified PI×1
Tao Sun, O.M.D
Beijing Tiantan Hospital
PI×1
Andreas Unterberg
Department of Neurosurgery, University Hospital Heidelberg
QC-verified PI×1
Sonikpreet Aulakh, MD
WVU Cancer Institute
MORGANTOWN, WV
QC-verified PI×1
Adrian Kilcoyne
Celularity inc
QC-verified PI×1
Marie-Andrée Fortin
Centre hospitalier de l'Université de Montréal (CHUM)
QC-verified PI×1
Motoo Nagane
Kyorin University Faculty of Medicine, Department of Neurosurgery
QC-verified PI×1
Zhixiong Lin
Capital Medical University
QC-verified PI×1
Donna Morgan Murray
Nativis, Inc.
QC-verified PI×1
Scott Grandy
Dahousie University and Nova Scotia Health Authority
QC-verified PI×1
Corinne E Griguer
University of Iowa
QC-verified PI×1
Rachel Grossman
Rare Disease / Clinical Research
PI×1
Charles Conrad
Rare Disease / Clinical Research
UT MD Anderson Cancer Center
PI×1
Michelle Kim
University of Michigan
QC-verified PI×1
Jean Aguiar, APRN
TVAX Biomedical, Inc
QC-verified PI×1
Nan Ji, Dr.
Beijing Tiantan Hospital
QC-verified PI×1
Radka Stoyanova
Rare Disease / Clinical Research
University of Miami
MIAMI, FL
PI×1

More about Giant cell glioblastoma

Disease overview →
Treatments →
Clinical trials →